InnoCare Pharma Limited
HKEX:9969.HK
5.77 (HKD) • At close September 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | InnoCare Pharma Limited |
Symbool | 9969.HK |
Munteenheid | HKD |
Prijs | 5.8 |
Beurswaarde | 8,687,994,000 |
Dividendpercentage | 0% |
52-weken bereik | 4.03 - 7.49 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jisong Cui Ph.D. |
Website | https://www.innocarepharma.com |
An error occurred while fetching data.
Over InnoCare Pharma Limited
InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (HKD)
Cijfers zijn in miljoenen (HKD)